1. Home
  2. JSPRW vs INDI Comparison

JSPRW vs INDI Comparison

Compare JSPRW & INDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPRW
  • INDI
  • Stock Information
  • Founded
  • JSPRW N/A
  • INDI 2007
  • Country
  • JSPRW United States
  • INDI United States
  • Employees
  • JSPRW 45
  • INDI N/A
  • Industry
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • INDI Semiconductors
  • Sector
  • JSPRW Health Care
  • INDI Technology
  • Exchange
  • JSPRW Nasdaq
  • INDI Nasdaq
  • Market Cap
  • JSPRW N/A
  • INDI N/A
  • IPO Year
  • JSPRW 2020
  • INDI N/A
  • Fundamental
  • Price
  • JSPRW $0.15
  • INDI $4.28
  • Analyst Decision
  • JSPRW
  • INDI Strong Buy
  • Analyst Count
  • JSPRW 0
  • INDI 5
  • Target Price
  • JSPRW N/A
  • INDI $8.70
  • AVG Volume (30 Days)
  • JSPRW N/A
  • INDI 4.2M
  • Earning Date
  • JSPRW N/A
  • INDI 02-20-2025
  • Dividend Yield
  • JSPRW N/A
  • INDI N/A
  • EPS Growth
  • JSPRW N/A
  • INDI N/A
  • EPS
  • JSPRW N/A
  • INDI N/A
  • Revenue
  • JSPRW N/A
  • INDI $228,806,000.00
  • Revenue This Year
  • JSPRW N/A
  • INDI N/A
  • Revenue Next Year
  • JSPRW N/A
  • INDI $40.57
  • P/E Ratio
  • JSPRW N/A
  • INDI N/A
  • Revenue Growth
  • JSPRW N/A
  • INDI 22.97
  • 52 Week Low
  • JSPRW N/A
  • INDI $3.16
  • 52 Week High
  • JSPRW N/A
  • INDI $7.82
  • Technical
  • Relative Strength Index (RSI)
  • JSPRW N/A
  • INDI 49.89
  • Support Level
  • JSPRW N/A
  • INDI $3.84
  • Resistance Level
  • JSPRW N/A
  • INDI $4.58
  • Average True Range (ATR)
  • JSPRW 0.00
  • INDI 0.29
  • MACD
  • JSPRW 0.00
  • INDI -0.00
  • Stochastic Oscillator
  • JSPRW 0.00
  • INDI 45.18

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: